Resonance Health Files New Provisional Patent
- 25 May 2020
Resonance Health Limited is pleased to announce that it has filed a provisional patent covering the application of novel Antisense Oligonucleotides (ASOs) to treat liver related disease.
Resonance Health News - April 2020
- 06 April 2020
Resonance Health is delighted to provide you with our latest customer newsletter, where you can find an update on all our latest acitvities.
To read the newsletter please click here
Resonance Health Partners with Siemens Healthineers
- 29 November 2019
Resonance Health is pleased to announce that it has entered into a Solution Partner Agreement with Siemens Healthcare GmbH (Siemens Healthineers), a leading medical technology company headquartered in Erlangen, Germany, for the distribution of the Company’s FerriSmart product through the Siemens Healthineers Digital Marketplace.
New Artificial Intelligence Tool for Automated Assessment of Liver Fat
- 21 November 2019
Resonance Health is pleased to announce that it has successfully trained a neural network (artificial intelligence, ‘AI’) for the automated assessment of liver fat from MRI data.
Resonance Health Files Provisional Patent
- 20 November 2019
Resonance Health is pleased to announce that it has filed a provisional patent for the discovery and use of novel blood markers to determine an individual’s iron status. These blood markers have been identified as part of the Company’s molecular medicine R&D program.
International Thalassaemia Day
- 08 May 2019
International Thalassaemia Day is a very special day that commemorates thalassemia patients everywhere.